Skip to main content

AACR 2023 Conference Highlights

mRNA Vaccine plus Immunotherapy Shows Promise in Melanoma
By Patricia Stewart
Emerging Therapies, AACR 2023 Conference Highlights, Melanoma, Skin Cancer
June 2023, Vol 13, No 6
During the 2023 American Association for Cancer Research Annual Meeting, experts presented results from a phase 2b clinical trial demonstrating a significant improvement in recurrence-free survival in patients with high-risk melanoma who were treated with a combination of an investigational personalized mRNA-based vaccine plus the immune checkpoint inhibitor pembrolizumab (Keytruda), compared with pembrolizumab alone. Read More ›
Study Highlights Need to Raise Awareness of Link Between HPV and Cancer
By Patricia Stewart
AACR 2023 Conference Highlights, Cervical Cancer, Gynecologic Cancers, AACR Highlights
May 2023, Vol 13, No 5
Vaccination against human papillomavirus (HPV) can prevent several types of cancer, including cervical, oral/oropharyngeal, penile, and anal cancers. Unfortunately, vaccination rates, as well as public knowledge regarding the link between HPV and these cancers, are lagging, according to research presented during the 2023 American Association for Cancer Research Annual Meeting. Read More ›